Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Cleaves phosphorylated sphingoid bases (PSBs), such as sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine. Additionally we are shipping SGPL1 Kits (10) and SGPL1 Proteins (10) and many more products for this protein.
Showing 10 out of 41 products:
Human Polyclonal SGPL1 Primary Antibody for EIA, IHC (p) - ABIN954782
Seo, Blake, Alexander, Hahm: Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. in Journal of virology 2010
Show all 2 references for ABIN954782
Human Polyclonal SGPL1 Primary Antibody for IF (p), IHC (p) - ABIN755128
Choi, de Poot, Lee, Kim, Han, Kim, Finley, Lee: Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. in Nature communications 2016
Cow (Bovine) Polyclonal SGPL1 Primary Antibody for WB - ABIN4620338
Van Veldhoven, Gijsbers, Mannaerts, Vermeesch, Brys: Human sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and mapping to chromosome 10q22(1). in Biochimica et biophysica acta 2000
Studies suggest that S1PL is a novel endogenous suppressor of pulmonary fibrosis in human idiopathic pulmonary fibrosis and animal models.
Although the observed inhibitory effect was not as strong as that of 4-deoxypyridoxine (a VB6 analog SPL inhibitor), these findings may be useful for further understanding the mechanism of action of THI.
upregulation of multidrug resistance transporters contributes to the chemoresistance of S1P (show S1PR1 Antibodies) lyase-deficient MEFs
Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3 (show STAT3 Antibodies)-activated microRNAs.
Findings suggest that sphingosine phosphate lyase (S1P (show S1PR1 Antibodies) lyase) expressed in the thymic medullary perivascular spaces keeps the tissue sphingosine 1-phosphate low around the vessels and promotes thymic egress via up-regulation of S1P receptor 1 (S1P1 (show S1PR1 Antibodies)).
Data indicate that SGPL1 sphingosine 1-phosphate lyase (aldolase (show ALD Antibodies)) mRNA is significantly increased in the periinfarct cortex.
Leukocyte Sgpl1 as critical factor in monocyte macrophage differentiation and function.
Inducible Sgpl1 knockout mice are protected in experimental autoimmune encephalomyelitis (EAE).
S1PL deficiency increases sphingolipid formation via recycling at the expense of de novo biosynthesis in neurons.
Data show that S1P (show S1PR1 Antibodies) lyase knockout mice with reduced S1P (show S1PR1 Antibodies) lyase activity (resulting in increased bio-available S1P (show S1PR1 Antibodies)) had improved survival compared with wild-type littermates.
increased SK and SPL mRNA expression along with reduced sphingosine 1-phosphate levels were more commonly observed in hepatocellular carcinoma tissues.
SPHK1 (show SPHK1 Antibodies):SGPL1 ratio correlated with increased cellular sphingosine-1-phosphate (S1P (show MBTPS1 Antibodies)), and S1P (show MBTPS1 Antibodies) correlated with drug resistance (IC50).
Results show that dissociation of SHP-1 (show PTPN6 Antibodies) from spinophilin (show PPP1R9B Antibodies) is followed by an increase in the binding of spinophilin (show PPP1R9B Antibodies) to PP1 (show PPA1 Antibodies).
S1P (show MBTPS1 Antibodies) lyase - by facilitating S1P1 (show S1PR1 Antibodies) receptor recycling - is essential for S1P (show MBTPS1 Antibodies)-mediated sustained signaling
results highlight the importance of S1P (show MBTPS1 Antibodies) in AD suggesting the existence of a global deregulation of S1P (show MBTPS1 Antibodies) signaling in this disease from its synthesis by SphK1 (show SPHK1 Antibodies) and degradation by SPL to its signaling by the S1P1 (show S1PR1 Antibodies) receptor.
The cells expressing SGPL1 in the parenchyma were CD68 (show CD68 Antibodies)(+) APCs (show APCS Antibodies).
Data show that a easy assay for 2-hydroxyacyl-CoA lyase (HACL1 (show HACL1 Antibodies)) and sphingosine-1-phosphate lyase (SGPL1) activities was developed.
SPL expression and activity are downregulated in cancerous tissues, there is a relationship between loss of SPL expression and prostate cancer aggressiveness.
S1P (show MBTPS1 Antibodies)(ext (show EXT1 Antibodies)) mediated endothelial cell motility is dependent on intracellular S1P (show MBTPS1 Antibodies) production, which is regulated, in part, by SphK1 (show SPHK1 Antibodies) and S1PL.
Cleaves phosphorylated sphingoid bases (PSBs), such as sphingosine-1-phosphate, into fatty aldehydes and phosphoethanolamine. Elevates stress-induced ceramide production and apoptosis.
sphingosine-1-phosphate lyase 1
, SP-lyase 1
, SPL 1
, sphingosine-1-phosphate aldolase
, sphingosine phosphate lyase 1